Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
Status:
Withdrawn
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This is a single center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3- LRX for
reduction of low density lipoprotein cholesterol (LDL-C) levels in patients with Homozygous
Familial Hypercholesterolemia (HoFH).